ATRC's cryoSPHERE MAX probe cuts freeze times by 50%, advancing Cryo Nerve Block therapy to improve post-op pain relief and reduce opioid dependency risks. MASON, Ohio, October 15, 2024--AtriCure ...

The cryoSPHERE MAX probe features a larger ball tip designed to optimize Cryo Nerve Block™ therapy (cryoNB). The new probe reduces freeze times by 50% when compared to AtriCure’s first ...

JPMorgan analyst Lilia-Celine Lozada assumed coverage of AtriCure (ATRC) with an Overweight rating and $40 price target With numbers reset and competitive headwinds not materializing as feared ...

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management ...

Dec. 20, 2024 — Investigations into precipitation patterns in eastern Central Europe since the end of the last ice age have shown that dynamic processes in atmospheric circulation, such as the ...

Abstract: We introduce ICE-TIDE, a method for cryogenic electron tomography (cryo-ET) that simultaneously aligns observations and reconstructs a high-resolution volume. The alignment of tilt series in ...

In the latest quarter, 6 analysts provided ratings for AtriCure (NASDAQ ... Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others.